Potential cardiovascular implications of Sea Buckthorn berry consumption in humans.
Diets rich in fruits and vegetables have been correlated with decreased risks of cardiovascular disease. Particularly, berry consumption has been associated with reductions in cardiovascular risk. Despite the range of potentially beneficial phytochemical components (vitamins, polyphenols, carotenoids, and fatty acids), there is little evidence underpinning the cardiovascular effects of sea buckthorn (SB) berries. The purpose of this review is to evaluate the benefits of SB consumption on cardiovascular health in human trials. Only six human studies were found, which examine the effect of SB berries on cardiovascular outcomes (i.e., lipid metabolism, platelet aggregation, and inflammation). Although there appears to be an inverse association between SB consumption and cardiovascular risk factors, the evidence is still scarce and the results are inconsistent. In addition, limitations in study design made it difficult to form firm conclusions. More "high-quality" human clinical trials are needed in order to establish the cardio-protective benefits of SB berries.
['Sayegh|Marietta|M|', 'Miglio|Cristiana|C|', 'Ray|Sumantra|S|']
D002318:Cardiovascular Diseases D002338:Carotenoids D004032:Diet D005227:Fatty Acids D005247:Feeding Behavior D005638:Fruit D031281:Hippophae D006801:Humans D064209:Phytochemicals D059808:Polyphenols D016032:Randomized Controlled Trials as Topic D012307:Risk Factors D014815:Vitamins
sea buckthorn berries platelet aggregation inflammation Blood lipids phytonutrients